WebDisclosure WebDisclosure
Basculer en Français
10964 Companies
240006 Keywords
168760 Articles
129121 Press releases
Headlines Articles Press releases ONCare Alliance, LLC Remove
  1. Home
  2. Companies
  3. ONCare Alliance, LLC
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 02/29/2024 at 17:05, 2 years 6 months ago

    Transformative Merger: ONCare Alliance, LLC Forges a New Path in Oncology and Cancer Care

    Data-driven Insights Cancer Care Oncology Healthcare Merger Independent Practice
  • BRIEF

    published on 02/29/2024 at 17:05, 2 years 6 months ago

    Fusion transformatrice : ONCare Alliance, LLC ouvre une nouvelle voie dans le domaine de l'oncologie et des soins contre le cancer

    Oncologie Soins Contre Le Cancer Fusion Des Soins De Santé Pratique Indépendante Informations Basées Sur Les Données
  • PRESS RELEASE

    published on 02/29/2024 at 17:00, 2 years 6 months ago

    Powerhouses QCCA and NCCA Merge to Create a Transformative New Entity in Independent Practice Oncology and Cancer Care: ONCare Alliance, LLC

    National Cancer Care Alliance (NCCA) and Quality Clinical Cancer Associates (QCCA) have merged to create ONCare Alliance, LLC, revolutionizing cancer care with data-driven insights and independent spirit
    Innovation Merger Cancer Care Independent Practice ONCare Alliance
    Logo of ONCare Alliance, LLC
Accesswire
  • Published on 09/11/2026 at 04:00, 5 hours 21 minutes ago

    Torq Announces Debt Settlement and Corporate Update

  • Published on 09/10/2026 at 22:25, 10 hours 56 minutes ago

    Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer

  • Published on 09/10/2026 at 17:46, 15 hours 35 minutes ago

    Groete Access Road Nears Completion

  • Published on 09/10/2026 at 15:20, 18 hours 1 minute ago

    MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026

  • Published on 09/10/2026 at 15:00, 18 hours 21 minutes ago

    All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE
EQS Group
  • Published on 09/11/2026 at 09:05, 16 minutes ago

    ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size

  • Published on 09/11/2026 at 09:00, 21 minutes ago

    Homann Holzwerkstoffe publishes its 2026 half-year report

  • Published on 09/11/2026 at 09:00, 21 minutes ago

    Picton Property Income Limited - Removal

  • Published on 09/11/2026 at 09:00, 21 minutes ago

    Official List Notice

  • Published on 09/11/2026 at 09:00, 21 minutes ago

    Mountain Alliance AG invests in Evolved Aerospace and expands its involvement in the European defence technology market

View all EQS
Les Echos
  • Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago

    Transparantiekennisgeving van Baltisse Groep

  • Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago

    Transparency notification by Baltisse Group

  • Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago

    BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY

  • Published on 09/11/2026 at 07:00, 2 hours 21 minutes ago

    BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ

  • Published on 09/10/2026 at 19:30, 13 hours 51 minutes ago

    Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2026 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy